Cetera Advisor Networks’s Bio-Techne TECH Stock Holding History

Cetera Advisor Networks’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$856K	Buy	12,165 +736	+6%	+$52.7K	﹤0.01%	1574
2023 Q4	$882K	Sell	11,429 -1,077	-9%	-$70.9K	﹤0.01%	1450
2023 Q3	$851K	Sell	12,506 -2,086	-14%	-$165K	0.01%	1385
2023 Q2	$1.19M	Sell	14,592 -793	-5%	-$63.7K	0.01%	1154
2023 Q1	$1.14M	Sell	15,385 -708	-4%	-$54.6K	0.01%	1155
2022 Q4	$1.33M	Buy	16,093 +6,041	+60%	+$480K	0.01%	1024
2022 Q3	$714K	Sell	10,052 -28	-0.3%	-$2.42K	0.01%	1078
2022 Q2	$873K	Buy	10,080 +7,960	+375%	+$746K	0.01%	950
2022 Q1	$230K	Hold	2,120	–	–	﹤0.01%	1800
2021 Q4	$274K	Buy	2,120 +440	+26%	+$53.9K	﹤0.01%	1672
2021 Q3	$204K	Buy	+1,680	New	+$204K	﹤0.01%	1785
2020 Q3	–	Sell	-952	Closed	-$63K	–	2843
2020 Q2	$63K	Buy	+952	New	+$57K	﹤0.01%	1776

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Cetera Advisor Networks's TECH Position: Q1 2024 in Review

Cetera Advisor Networks increased its Bio-Techne (TECH) stake by 6.4% in Q1 2024, buying an estimated $52.7K and bringing the position to 12,165 shares worth $856K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Cetera Advisor Networks first reported a position in TECH in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.33M in Q4 2022. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2024.

Cetera Advisor Networks held 12,165 shares of Bio-Techne worth $856K as of Q1 2024.
Cetera Advisor Networks bought 736 Bio-Techne shares in Q1 2024, an estimated $52.7K.
Bio-Techne made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1574 holding.
Cetera Advisor Networks first reported a position in Bio-Techne in Q2 2020 and has held it in 12 quarters since.
Cetera Advisor Networks's Bio-Techne position peaked at $1.33M in Q4 2022.
557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.